Fortrea Holdings is trading 5.31% up now at $21.07, alongside a broad September 17, 2026 risk-on recovery.
- The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average are all higher, supporting healthcare and growth-stock sentiment.
- No new company-specific announcement clearly explains the move.
- Fortrea’s previously announced approximately $45 million Worldwide Clinical Trials acquisition remains relevant background; it was disclosed September 2, 2026, not September 17.